Two Sigma Advisers
ACHV icon

Two Sigma Advisers’s Achieve Life Sciences ACHV Stock Holding History

Two Sigma Advisers’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-209,900
Closed -$1.04M – 22
2025
Q4 		$1.04M Buy
209,900
+99,600
+90% +$434K ﹤0.01% 1462
2025
Q3 		$347K Buy
+110,300
New +$303K ﹤0.01% 1911
2022
Q2 		– Sell
-12,485
Closed -$95K – 2624
2022
Q1 		$95K Sell
12,485
-4,770
-28% -$35.5K ﹤0.01% 2512
2021
Q4 		$134K Sell
17,255
-11,600
-40% -$91.2K ﹤0.01% 2375
2021
Q3 		$245K Sell
28,855
-14,400
-33% -$113K ﹤0.01% 2182
2021
Q2 		$388K Buy
+43,255
New +$412K ﹤0.01% 2049
2020
Q2 		– Sell
-2,605
Closed -$17K – 2477
2020
Q1 		$17K Buy
+2,605
New +$25.2K ﹤0.01% 2417
2015
Q3 		– Sell
-11
Closed -$59K – 1787
2015
Q2 		$59K Sell
11
-8
-42% -$39.7K ﹤0.01% 1833
2015
Q1 		$89K Buy
19
+2
+12% +$9.82K ﹤0.01% 1801
2014
Q4 		$84K Buy
+17
New +$83.1K ﹤0.01% 2345

Other funds holding ACHV

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers's ACHV Position: Q1 2026 in Review

Two Sigma Advisers sold out of Achieve Life Sciences (ACHV) in Q1 2026, closing a stake of 209,900 shares — an estimated $1.04M sold.

Two Sigma Advisers first reported a position in ACHV in Q4 2014 and held it in 10 quarters. The position peaked at $1.04M in Q4 2025. 81 funds tracked by Wall St. Rank hold ACHV as of Q1 2026.

  • Two Sigma Advisers reported no remaining Achieve Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 209,900 Achieve Life Sciences shares in Q1 2026, an estimated $1.04M.
  • Two Sigma Advisers first reported a position in Achieve Life Sciences in Q4 2014 and held it in 10 quarters.
  • Two Sigma Advisers's Achieve Life Sciences position peaked at $1.04M in Q4 2025.
  • 81 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.